首页> 外文期刊>Journal of Nephropathology >A rare case of focal segmental glomerular sclerosis and subsequent necrotizing crescentic glomerulonephritis in the same patient
【24h】

A rare case of focal segmental glomerular sclerosis and subsequent necrotizing crescentic glomerulonephritis in the same patient

机译:同一患者中罕见的局灶节段性肾小球硬化和随后的坏死性新月形肾小球肾炎

获取原文
       

摘要

Background : Focal segmental glomerular sclerosis (FSGS) and necrotizing crescentic glomerulonephritis is a rare combination of diagnoses in the same patient. We report on a patient with FSGS who 10 years later developed anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. Case Presentation : Patient is a 60-year-old female with chronic kidney disease stage 3, osteopenia and anemia. In 2007, she was positive for ANCA proteinase-3 antibody, but kidney biopsy revealed FSGS. She was treated with high-dose oral steroids with tapered dose and went into remission. In 2017, she developed acute renal failure with increased proteinuria. Despite prior FSGS diagnosis, her new kidney biopsy revealed pauci-immune necrotizing glomerulonephritis. Patient was treated with methylprednisolone 250 mg IV for three days and high dose oral steroids with tapered dose. She was also started on rituximab 375 mg/m2 IV once weekly for 4 doses. Given the extent of kidney damage, the patient decided to start peritoneal dialysis and she is also on the kidney transplant list. Conclusions : The rare concurrence of FSGS and ANCA associated glomerulonephritis has not yet been reported. The case also emphasizes the significance of screening for ANCA or obtaining kidney biopsy when indicated not only as the gold standard for diagnosis but also as prognostic value.
机译:背景:局灶性节段性肾小球硬化症(FSGS)和坏死性新月形肾小球肾炎是同一患者中罕见的诊断组合。我们报道了一名FSGS患者,该患者在10年后发展出抗中性粒细胞胞浆抗体(ANCA)相关性肾小球肾炎。病例报告:患者是一名60岁女性,患有慢性肾脏疾病3期,骨质减少和贫血。 2007年,她的ANCA蛋白酶3抗体呈阳性,但肾脏活检显示FSGS。她接受了逐渐减量的大剂量口服类固醇激素治疗,并获得缓解。 2017年,她发生了急性肾功能衰竭并伴有蛋白尿增加。尽管先前有FSGS诊断,但她的新肾脏活检显示出免疫性坏死性肾小球肾炎。患者接受甲基泼尼松龙250 mg静脉注射三天和高剂量口服类固醇并逐渐减少剂量。她还每周一次开始接受375 mg / m2的利妥昔单抗静脉注射,共4剂。考虑到肾脏损害的程度,患者决定开始腹膜透析,她也列在肾脏移植名单上。结论:尚未报道FSGS和ANCA相关性肾小球肾炎的罕见并发。该病例还强调了筛查ANCA或进行肾脏活检的重要性,这不仅是诊断的金标准,而且还具有预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号